BCTXZ
BriaCell Therapeutics Corp.
NASDAQ · Healthcare · Biotechnology · CA
$0.11
+3.99%Margins
Gross margin
50.0%
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-224.3%
Return on equity
-148.0%
Return on assets
-208.3%
Return on invested capital
-0.00x
Asset turnover
-$71.5M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jul 1, 2026